Procathepsin-L, a proteinase that cleaves human C3 (the third component of complement), confers high tumorigenic and metastatic properties to human melanoma cells

Cancer Research

Volumn 58, Issue 13, 1998, Pages 2733-2736

  Frade, Raymond ^a   Rodrigues Lima, Fernando ^a   Huang, Suyun ^b   Xie, Keping ^b   Guillaume, Nathalie ^a   Bar Eli, Menashe ^b  

^a HÔPITAL SAINT ANTOINE   (France)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN; CELL SURFACE PROTEIN; CYSTEINE PROTEINASE; PROCATHEPSIN L; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; COMPLEMENT SYSTEM; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MELANOMA CELL; METASTASIS; MOLECULAR CLONING; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; TUMOR GROWTH; TUMOR IMMUNITY;

EID: 0032126503     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Müller-Eberhard, H. J., and Schreiber, R. D. Molecular biology and chemistry of the alternative pathway of complement. Adv. Immunol., 29: 1-53, 1980.
2. Erdei, A., Fust, G., and Gergely, J. The role of C3 in the immune response. Immunol. Today, 12: 332-337, 1991.
3. Frade, R., Myones, B. L., Barel, M., Krikorian, L., Charriaut, C., and Ross, G. D. Gp140, a C3b binding membrane component of B lymphocytes is the C3d/C3dg receptor (CR2) and is distinct from the neutrophils C3dg receptor (CR4). Eur. J. Immunol., 15: 1192-1197, 1985.
4. Frade, R., Hermann, J., and Barel, M. A 16 amino acid synthetic peptide derived from human C3d, triggers proliferation and specific tyrosine-phosphorylation of transformed CR2-positive human lymphocytes and of normal resting B lymphocytes. Biochem. Biophys. Res. Commun., 188: 833-842, 1992.
5. Charriaut-Marlangue, C., Barel, M., and Frade, R. Identification of p57, a serine proteinase, from human erythrocyte membranes, which cleaves both chains of human third component (C3) of complement. Biochem. Biophys. Res. Commun., 140: 1113-1120, 1986.
6. Hermann, J., Barel, M., and Frade, R. Human erythrocyte ankyrin, a cytoskeleton component generates the p57 membrane proteinase which cleaves C3, the third component of complement. Biochem. Biophys. Res. Commun., 204: 453-460, 1994.
7. Ollert, M. W., Frade, R., Fiandino, A., Panneerselvam, M., Petrella, E. C., Barel, M., Pangburn, M. K., Bredehorst, R., and Vogel, C. W. C3-cleaving proteinase: a new complement regulatory protein of human melanoma cells. J. Immunol., 144: 3862-3867, 1990.
8. Jean, D., Hermann, J., Rodrigues-Lima, F., Barel, M., Balbo, M., and Frade, R. Identification on melanoma cells of p39, a cysteine proteinase which cleaves C3, the third component of complement: amino acid sequence identities with procathepsin L. Biochem. J., 312: 961-969, 1995.
9. Jean, D., Bar-Eli, M., Huang, S., Xie, K., Rodrigues-Lima, F., Hermann, J., and Frade, R. A cysteine proteinase, which cleaves human C3, the third component of complement, is involved in tumorigenicity and metastasis of human melanoma. Cancer Res., 56: 254-258, 1996.
10. Jean, D., Rodrigues-Lima, F., Cassinat, B., Hermann, J., Cabane, J., and Frade, R. Co-expression and secretion of C3, the third component of complement and a C3-cleaving cysteine proteinase in a highly metastatic human melanoma cell line. Immunol. Lett., 58: 107-112, 1997.
11. Zhang, R. D., Price, J. E., Schackert, G., Itoh, K., and Fidler, I. J. Malignant potential of cells isolated from lymph node or brain metastases of melanoma patients and implications for prognosis. Cancer Res., 51: 2029-2035, 1991.
12. Gal, S., and Gottesman, M. M. Isolation and sequence of a cDNA for human procathepsin-L. Biochem. J., 253: 303-306, 1988.
13. Xie, S., Luca, M., Huang, S., Gutman, M., Reich, R., Johnson, J. P., and Bar-Eli, M. Expression of MCAM/MUC18 by human melanoma cells leads to increased tumor growth and metastasis. Cancer Res., 57: 2295-2303, 1997.
14. Rozhin, J., Wade, R. L., Honn, K. V., and Sloane, B. F. Membrane-associated cathepsin L: a role in metastasis of melanomas. Biochem. Biophys. Res. Commun., 164: 556-561, 1989.
15. Parck, I. C., Lee, S. Y., Jeon, D. G., Lee, J. S., Hwang, C. S., Hwang, B. G., Lee, S. H., Hong, W. S., and Hong, S. I. Enhanced expression of cathepsin-L in metastatic bone tumors. J. Korean Med. Sci., 11: 144-148, 1996.
16. Hiedtmann, H. H., Salge, U., Havemann, K., Kirschke, H., and Wiederanders, B. Secretion of latent, acid-activatable cathepsin-L precursor by human non-small cell lung cancer cell lines. Oncol. Res., 5: 441-451, 1993.
17. Sivaparvathi, M., Yamamoto, M., Nicolson, G. L., Gokaslan, Z. L., Fuller, G. N., Liotta, L. A., Sawaya, R., and Rao, J. S. Expression and immunohistochemical localization of cathepsin-L during the progression of human gliomas. Clin. Exp. Metastasis, 14: 27-34, 1996.
18. Adenis, A., Huet, G., Zerimech, F., Hecquet, B., Balduyck, M., and Peyrat, J. P. Cathepsin B, L, and D activities in colorectal carcinomas: relationship with clinicopathological parameters. Cancer Lett., 96: 267-275, 1995.
19. Nishida, Y., Kohno, K., Kawamata, T., Morimitsu, K., Kuwano, M., and Miyakawa, I. Increased cathepsin-L levels in serum in some patients with ovarian cancer: comparison with CA125 and CA72-4. Gynecol. Oncol., 56: 357-361, 1995.
20. Thomssen, C., Schmitt, M., Goretzki, L., Oppelt, P., Pache, L., Dettmar, P., Jänicke, F., and Graeff, H. Prognostic values of the cysteine proteases cathepsin B and cathepsin L in human breast cancer. Clin. Cancer Res., 1: 741-746, 1995.